Clinical Trial Update: Treatment of Severe Ocular Chemical Burns by Subconjunctival Injection of Allogeneic Mesenchymal Stem Cells: An Open-Label, Single-Arm, Multicenter Phase II Trial [Phase 2]

View source ↗

Summary

Phase II open-label, single-arm multicenter trial evaluating subconjunctival injection of allogeneic mesenchymal stem cells for severe ocular chemical burns; cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Chemical Burns

Drugs mentioned

• Allogeneic mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Fondation Ophtalmologique Adolphe de Rothschild | Conditions: Chemical Burns, Ocular Burns | Phase 2 | Status: NOT_YET_RECRUITING